Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.
about
Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic ReviewCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsStem/progenitor cells in endogenous repairing responses: new toolbox for the treatment of acute lung injuryImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyMesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza.Interactions between rat alveolar epithelial cells and bone marrow-derived mesenchymal stem cells: an in vitro co-culture model.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin woundsInfluenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysemaDesign and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndromeHuman mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia.Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.Mesenchymal stem cell therapy for acute respiratory distress syndrome: a light at the end of the tunnel?Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS.Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injuryHuman mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytesPreclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.Expanded endothelial progenitor cells mitigate lung injury in septic mice.Cellular Therapies in Trauma and Critical Care Medicine: Forging New FrontiersTherapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteriaTherapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.Bone Marrow-Derived Mesenchymal Stem Cells Enhance Bacterial Clearance and Preserve Bioprosthetic Integrity in a Model of Mesh Infection.Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium.Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin- 2 via toll- like receptor 4 signallingPhase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based TherapiesAlveolar Fluid Clearance in Pathologically Relevant Conditions: In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome.
P2860
Q26773048-367B2126-F6E7-44A0-9D29-8E8CA279A9E2Q27026350-47DA8B54-370F-4917-804D-8329E99A3BBBQ28071916-C06552EB-23A5-41E9-8D92-AB6EDA785FAAQ28079971-35BE2849-DA06-43B9-B7EC-39FCA7D00945Q29994669-094F04C0-2F43-4D7A-AB43-0BD945FB0318Q30353064-819105F0-0AAA-4BB3-B325-9AF2E9133FA4Q30655698-159AFC2F-1A46-4C39-AECF-D9BA0EDBD755Q33722631-B374C365-7CDB-471E-9682-453CC798E023Q33783282-6FE7A38D-D02B-4F91-8F12-3D00DF1FE080Q33869297-39C6D551-5761-471A-B9CA-D26A730FD19EQ34131746-CA03325C-EE4F-40A5-945F-287687331373Q34306572-CEF3E6F5-748F-4CF1-B498-2A8428F1D520Q34756148-391548E0-7021-4B01-A3B4-F162BB6FE93BQ34824071-308516AE-0C73-4B30-B5BF-ACFCFB6DD8A2Q34979725-5603582A-0576-411C-9357-BDB75B6F95B2Q34995619-239A61E5-01E0-40C1-AB4C-59A662FCA3BFQ35153085-5F5E6D57-0E41-47AD-974D-98B7F8F021C9Q35196768-90EC2D9A-6C14-4C71-AB71-2B5B1E7E1B7DQ35205677-3CEC025D-F898-439E-BBE0-2907E10A7094Q35604449-E57968FA-F059-416F-873E-FB3B1D5A99D3Q35672031-811A0365-8B14-4351-ADEB-3364278990EBQ35809674-99CC9083-4BD8-4980-BAC4-EE27217EA636Q35994803-920735E4-A3F7-4716-8A6C-5B61D6442CB6Q36046310-42F0E585-195C-4D20-97A5-E0DFEEDDD8EDQ36067836-F9BE0CB4-2FFD-4CE0-9647-E861B3A4E1F7Q36096318-F6FE050A-6E58-4A27-9299-7D01CFAA4488Q36212648-6DEE9C2A-1ED5-4234-973F-9EE5D3E7307AQ36322012-A7AA47C5-C2F0-413B-BD7A-A882084DC94AQ36852274-5EED69A8-4108-4BFB-948B-4DBF77A91A8EQ36917444-EE215D92-8B21-4E94-9F00-192633A46F8AQ36998206-7AFF5150-2912-4B2D-9DF1-8D5F937511ADQ37117016-64F825B9-E346-4C73-B5B1-0CC6BB16122BQ37191014-0A083B27-02E8-43A4-B42E-FBF06C5A0407Q37245154-DB8B5A9A-4BF0-4FE7-B2DC-0FD212781A97Q37325949-BE5A7953-BEB9-4952-B4D8-E0F1B7E083FAQ37576082-335BC67F-5B0D-4DD7-A2FC-E6894E32DB44Q37614303-E2DDE77B-68B5-491A-8F06-A05A09CF18DDQ37651549-3BA7C546-9658-4DA5-A23D-0D77226C94A7Q37727501-2D0B147F-E617-46D6-B284-31763B4A4CB7Q37740568-B9ADC276-B731-4615-8B6D-53CA6481B283
P2860
Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@en
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@nl
type
label
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@en
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@nl
prefLabel
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@en
Mesenchymal stem cells enhance ...... ne Escherichia coli pneumonia.
@nl
P2093
P2860
P1433
P1476
Mesenchymal stem cells enhance ...... ine Escherichia coli pneumonia
@en
P2093
Majd Mouded
Maria Kapetanaki
Naveen Gupta
Vladimir Serikov
Xinping Tan
P2860
P304
P356
10.1136/THORAXJNL-2011-201176
P407
P577
2012-01-16T00:00:00Z